- Home
- ULH vs LYEL Comparison
ULH vs LYEL Comparison
Compare ULH & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ULH | LYEL |
|---|---|---|
| Founded | 1932 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 462.1M | 490.1M |
| IPO Year | 2004 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ULH | LYEL |
|---|---|---|
| Price | $20.85 | $23.67 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $20.00 | ★ $30.60 |
| AVG Volume (30 Days) | 50.3K | ★ 76.6K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,461,708,000.00 | $36,000.00 |
| Revenue This Year | $4.02 | N/A |
| Revenue Next Year | $3.02 | $16,285.34 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.78 | $0.39 |
| 52 Week High | $30.76 | $45.00 |
Technical Indicators
Market Signals| Indicator | ULH | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 54.89 | 56.32 |
| Support Level | $14.23 | $21.27 |
| Resistance Level | $23.49 | $27.30 |
| Average True Range (ATR) | 1.46 | 1.70 |
| MACD | -0.12 | 0.49 |
| Stochastic Oscillator | 40.11 | 77.99 |
Price Performance
Historical ComparisonAbout ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.